{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:03:46Z","timestamp":1785539026369,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030898","name":"Institut canadien d'information sur la sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jacadv.2026.102860","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:03:28Z","timestamp":1782237808000},"page":"102860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Burden of Cardiovascular Disease in Lymphoma Survivors"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1025-5480","authenticated-orcid":false,"given":"Christopher","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gazelle","family":"Halajha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Prica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abi","family":"Vijenthira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiming","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paaladinesh","family":"Thavendiranathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Abdel-Qadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2026.102860_bib1","author":"Surveillance Research Program"},{"issue":"11","key":"10.1016\/j.jacadv.2026.102860_bib2","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/ajh.26717","article-title":"Hodgkin lymphoma: 2023 update on diagnosis, risk-stratification, and management","volume":"97","author":"Ansell","year":"2022","journal-title":"Am J Hematol"},{"issue":"10091","key":"10.1016\/j.jacadv.2026.102860_bib3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","article-title":"Non-Hodgkin lymphoma","volume":"390","author":"Armitage","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jacadv.2026.102860_bib4","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","article-title":"Late cardiotoxicity after treatment for Hodgkin Lymphoma","volume":"109","author":"Aleman","year":"2007","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.jacadv.2026.102860_bib5","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","article-title":"Long-term cause-specific mortality of patients treated for Hodgkin's disease","volume":"21","author":"Aleman","year":"2003","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.jacadv.2026.102860_bib6","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1200\/JCO.1993.11.7.1208","article-title":"Cardiac disease following treatment of Hodgkin's disease in children and adolescents","volume":"11","author":"Hancock","year":"1993","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.jacadv.2026.102860_bib7","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1001\/jama.290.21.2831","article-title":"Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy","volume":"290","author":"Hull","year":"2003","journal-title":"JAMA"},{"issue":"41","key":"10.1016\/j.jacadv.2026.102860_bib8","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacadv.2026.102860_bib9","first-page":"1135","article-title":"ICES: data, discovery, better health","volume":"4","author":"Schull","year":"2020","journal-title":"Int J Popul Data Sci"},{"issue":"8 Suppl 2","key":"10.1016\/j.jacadv.2026.102860_bib10","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1007\/BF03403823","article-title":"Development of the Canadian Marginalization Index: a new tool for the study of inequality","volume":"103","author":"Matheson","year":"2012","journal-title":"Can J Public Health"},{"issue":"5","key":"10.1016\/j.jacadv.2026.102860_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0895-4356(88)90052-2","article-title":"An application of capture-recapture methods to the estimation of completeness of cancer registration","volume":"41","author":"Robles","year":"1988","journal-title":"J Clin Epidemiol"},{"issue":"16","key":"10.1016\/j.jacadv.2026.102860_bib13","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1182\/blood-2016-09-740332","article-title":"Risk of heart failure in survivors of Hodgkin Lymphoma: effects of cardiac exposure to radiation and anthracyclines","volume":"129","author":"van Nimwegen","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jacadv.2026.102860_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.24095\/hpcdp.33.3.06","article-title":"Identifying cases of congestive heart failure from administrative data: a validation study using primary care patient records","volume":"33","author":"Schultz","year":"2013","journal-title":"Chronic Dis Inj Can"},{"issue":"12","key":"10.1016\/j.jacadv.2026.102860_bib15","first-page":"1561","article-title":"Identifying patients with atrial fibrillation in administrative data","volume":"32","author":"Tu","year":"2016","journal-title":"Can J Cardiol"},{"issue":"6","key":"10.1016\/j.jacadv.2026.102860_bib16","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Communications Statistics Simulation Computation"},{"issue":"24","key":"10.1016\/j.jacadv.2026.102860_bib17","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1001\/jama.2024.4970","article-title":"Accounting for competing risks in clinical research","volume":"331","author":"Austin","year":"2024","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.jacadv.2026.102860_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/sim.8399","article-title":"A review of the use of time-varying covariates in the Fine-Gray subdistribution hazard competing risk regression model","volume":"39","author":"Austin","year":"2020","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.jacadv.2026.102860_bib19","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/sim.9259","article-title":"Using fractional polynomials and restricted cubic splines to model non-proportional hazards or time-varying covariate effects in the Cox regression model","volume":"41","author":"Austin","year":"2022","journal-title":"Stat Med"},{"issue":"10203","key":"10.1016\/j.jacadv.2026.102860_bib20","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(19)31674-5","article-title":"Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases","volume":"394","author":"Strongman","year":"2019","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jacadv.2026.102860_bib21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/ajh.26230","article-title":"Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era","volume":"96","author":"Boddicker","year":"2021","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.jacadv.2026.102860_bib22","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin Lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.jacadv.2026.102860_bib23","first-page":"19","article-title":"Long-term cardiac effects of modern treatment for Hodgkin's Lymphoma","volume":"10","author":"Bjerring","year":"2024","journal-title":"Cardiooncology"},{"issue":"9","key":"10.1016\/j.jacadv.2026.102860_bib24","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1002\/cam4.1572","article-title":"Long-term risk of cardiovascular mortality in lymphoma survivors: a systematic review and meta-analysis","volume":"7","author":"Boyne","year":"2018","journal-title":"Cancer Med"},{"issue":"10","key":"10.1016\/j.jacadv.2026.102860_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.135","article-title":"Treatment for lymphoma and late cardiovascular disease risk: a systematic review and meta-analysis","volume":"2","author":"Stone","year":"2019","journal-title":"Health Sci Rep"},{"issue":"12","key":"10.1016\/j.jacadv.2026.102860_bib26","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1200\/JCO.18.00605","article-title":"First-line treatment of patients with indolent non-hodgkin lymphoma or mantle-cell lymphoma with bendamustine plus Rituximab versus R-CHOP or R-CVP: results of the BRIGHT 5-year follow-up study","volume":"37","author":"Flinn","year":"2019","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jacadv.2026.102860_bib27","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jacadv.2026.102860_bib28","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/s41467-020-15639-5","article-title":"Fatal heart disease among cancer patients","volume":"11","author":"Stoltzfus","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.jacadv.2026.102860_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jnci\/djaa096","article-title":"All-Cause and cardiovascular disease mortality among breast cancer survivors in CLUE II, a long-standing community-based cohort","volume":"113","author":"Ramin","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.jacadv.2026.102860_bib30","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jama.2023.11887","article-title":"Atorvastatin for anthracycline-associated cardia2c dysfunction: the STOP-CA randomized clinical trial","volume":"330","author":"Neilan","year":"2023","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jacadv.2026.102860_bib31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/ehjcvp\/pvad031","article-title":"Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines","volume":"9","author":"Thavendiranathan","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26002814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26002814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:21:39Z","timestamp":1785529299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26002814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2772963X26002814"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102860","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Burden of Cardiovascular Disease in Lymphoma Survivors","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102860","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102860"}}